LBIRD

FR0000038242

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 11:35:11 2024-05-21 am EDT			5-day change	1st Jan Change
12.9 ^EUR	+0.78%		-3.01%	+5.91%

May. 03	Lumibird launches product for dry eyes	CF
Apr. 23	Lumibird: over 7% growth in quarterly sales	CF

Lumibird SA Provides Revenue Guidance for the Year 2023

March 17, 2022 at 12:45 pm EDT

Lumibird SA provided revenue guidance for the year 2023. For the year, the company expects revenues to exceed €250 million, with the combined impact of organic and external growth.

Latest news about LUMIBIRD

Lumibird launches product for dry eyes	May. 03	CF
Lumibird: over 7% growth in quarterly sales	Apr. 23	CF
Lumibird: EBITDA improved by 10% in 2023	Mar. 13	CF
Lumibird SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12	CI
Lumibird: two orders from Saab for OdiPro	Mar. 01	CF
Lumibird: the stock outperforms after a positive note	Feb. 19	CF
Lumibird: sales up by almost 7% in 2023	Jan. 30	CF
The LUMIBIRD Group Reports Unaudited Consolidated Sales Results for the Fourth Quarter and Full Year Ended 31 December 2023	Jan. 29	CI
Lumibird: heavy decline after target adjustment	Dec. 15	CF
Lumibird: towards a technological partnership for Cilas	Nov. 24	CF
Lumibird: HoloDoppler project subsidized by Bpifrance	Nov. 16	CF
Lumibird: 11% rise in nine-month sales	23-10-25	CF
Lumibird SA Provides Revenues Guidance for the Fourth Quarter and Full Year 2023	23-10-24	CI
Lumibird SA Reports Unaudited Consolidated Revenue Results for the Third Quarter and Nine Months of 2023	23-10-24	CI
Lumibird: surrounded after its half-year results	23-09-27	CF
Lumibird SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-27	CI
Lumibird: major defense contract	23-09-15	CF
Lumibird Signs Major Contract for Laser Rangefinders for Defence Applications	23-09-14	CI
Lumibird: acquisition from Prima Industrie finalized	23-09-01	CF
Lumibird Closes Purchase of Prima Industrie's Convergent Photonics Unit, North American Assets	23-09-01	MT
Lumibird SA (ENXTPA:LBIRD completed the acquisition of Convergent Photonics Italia S.r.l and Convergent assets of Prima Industrie North America from Prima Industrie SpA.	23-08-31	CI
Lumibird: acclaimed for its half-year trading update	23-07-25	CF
Tranche Update on Lumibird SA's Equity Buyback Plan announced on July 5, 2023.	23-07-05	CI
Lumibird SA announces an Equity Buyback for 50,000 shares.	23-07-05	CI
Lumibird SA announces an Equity Buyback.	23-07-05	CI

LUMIBIRD figure parmi les plus grands spécialistes mondiaux du laser. Fort de 50 années d'expérience et maîtrisant les technologies de laser à solides, de diodes laser et de laser à fibres, LUMIBIRD conçoit, fabrique et distribue des lasers haute performance à usages scientifiques (laboratoires de recherche et universités), industriels (production, défense/spatial, capteurs Lidar) et médical (ophtalmologie).

Sector

Advanced Medical Equipment & Technology

Calendar

06:30am - Capital Markets Day

More about the company

Income Statement Evolution

More financial data

Ratings for LUMIBIRD

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

12.8 EUR

Average target price

17.75 EUR

Spread / Average Target

+38.67%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
LUMIBIRD	+5.91%	307M
THERMO FISHER SCIENTIFIC	+11.18%	227B
DANAHER CORPORATION	+15.22%	198B
INTUITIVE SURGICAL, INC.	+19.19%	142B
BOSTON SCIENTIFIC CORPORATION	+30.89%	111B
SIEMENS HEALTHINEERS AG	+1.56%	64.16B
EDWARDS LIFESCIENCES CORPORATION	+18.48%	54.1B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+5.12%	51.41B
AGILENT TECHNOLOGIES, INC.	+10.53%	45.32B
GE HEALTHCARE TECHNOLOGIES INC.	+5.98%	37.32B

Other Advanced Medical Equipment & Technology

LUMIBIRD

Equities

LBIRD

FR0000038242

Advanced Medical Equipment & Technology

Lumibird SA Provides Revenue Guidance for the Year 2023

Latest news about LUMIBIRD

Chart LUMIBIRD

Company Profile

Income Statement Evolution

Ratings for LUMIBIRD

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Advanced Medical Equipment & Technology